Human Factor IX variants with an extended half life

Details for Australian Patent Application No. 2008311973 (hide)

Owner Inspiration Biopharmaceuticals, Inc. The University of North Carolina at Chapel Hill

Inventors Stafford, Darrel W.; Feng, Dengmin; Mann, David M.

Agent Fisher Adams Kelly

Pub. Number AU-A-2008311973

PCT Pub. Number WO2009/051717

Priority 60/999,035 15.10.07 US

Filing date 15 October 2008

Wipo publication date 23 April 2009

International Classifications

A61K 38/37 (2006.01) Medicinal preparations containing peptides

C07K 14/74 (2006.01) Peptides having more than 20 amino acids

C07K 14/745 (2006.01) Peptides having more than 20 amino acids

C12N 9/64 (2006.01) Enzymes, e.g. ligases (6.) - derived from animal tissue, e.g. rennin

Event Publications

20 May 2010 PCT application entered the National Phase

  PCT publication WO2009/051717 Priority application(s): WO2009/051717

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008311974-Calcium receptor modulating agents

2008311971-Quinolizidinone M1 receptor positive allosteric modulators